References
- Allen JC, Walker R, Luks E, Jennings M, Barfoot S, Tan C. Carboplatin and recurrent childhood brain tumors. Journal of Clinical Oncology 1987; 5: 459–463
- Al-Waili NS, Butler GJ. A combination of radiotherapy, nitric oxide and a hyperoxygenation sensitizing protocol for brain malignant tumor treatment. Medical Hypotheses 2007; 68: 528–537
- Chougule PB, Akhtar MS, Akerley W, Ready N, Safran H, McRae R, Nigri P, Bellino J, Koness J, Radie-Keane K, et al. Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study. Seminars in Radiation Oncology 1999; 9(2 Suppl. 1)58–63
- Culot M, Lundquist S, Vanuxeem D, Nion S, Landry C, Delplace Y, Dehouck MP, Berezowski V, Fenart L, Cecchelli R. An in vitro blood–brain barrier model for high throughput (HTS) toxicological screening. Toxicology In Vitro 2008; 22: 799–811
- Rump AF, Siekmann U, Kalff G. Effects of hyperbaric and hyperoxic conditions on the disposition of drugs: Theoretical considerations and a review of the literature. General Pharmacology 1999; 32: 127–133
- Suzuki Y, Tanaka K, Shimizu M, Yoshida Y, Hashimoto T, Yamazaki H. Prediction of efficacy for malignant gliomas treated with carboplatin by pharmacokinetic parameters in combination with hyperbaric oxygenation. Neurologia medico-chirurgica. 2008, In Press.
- Tanaka K, Yoshida Y, Hashimoto T, Gamura S, Shimizu M, Aoyama T, Yamazaki H. Pharmacokinetics of anti-cancer drug with hyperbaric oxygenation therapy. Neuro-Oncology 2005; 15: 7–10, [in Japanese]
- Tanaka K, Yoshida Y, Hashimoto T, Suga M, Yoshida K. Statistical study of chemotherapy for malignant gliomas. Neuro-Oncology 2004; 14: 15–18, [in Japanese]
- Yamazaki H, Shimizu M, Murayama N, Tanaka K, Nion S, Cecchelli R. forthcoming. Increased transendothelial permeability of anti-cancer agent carboplatin with aid of hyperbaric oxygenation. Xenobiotica 2008; 38: 1298–1304
- Yamazaki H, Tanaka K, Gamura S, Hashimoto T, Shimizu M. High-performance liquid chromatographic assay for carboplatin in ultrafiltered plasma combined with hyperbaric oxygenation. Drug Metabolism and Pharmacokinetics 2006; 21: 429–431